Scientists develop more accurate test for cervical cancer
The IndependentSign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. In turn, our approaches to cervical screening must adapt so that programmes continue to deliver benefit Professor Martin Widschwendter, University College London For those without cell changes, but who had human papillomavirus which causes most cases of cervical cancer, it detected 55% of people who would have cell changes in the next four years. Building new, holistic, risk-predictive screening programmes around existing, effective cervical sample collection offers real potential for cancer prevention in the future Professor Martin Widschwendter, University College London Previous studies on the new test using cervical samples have suggested accuracy in predicting women with breast or ovarian cancer. Professor Martin Widschwendter, from University College London’s department of women’s cancer, said: “Vaccination against the virus that causes cervical cancer is now widely implemented and is leading to changes in the amount and types of the virus circulating in the community. This new method is more specific and doesn’t lead to over-treatment which is good news for cervical cancer prevention and great news for everyone who needs to be screened Athena Lamnisos, Eve Appeal “Building new, holistic, risk-predictive screening programmes around existing, effective cervical sample collection offers real potential for cancer prevention in the future.” Athena Lamnisos, chief executive of the Eve Appeal charity, said: “It’s so welcome to see screening tools and predictive tests becoming more effective.